immunohistochemistry

You have access
Differences of HER2 Status by HercepTest and PATHWAY 4B5 Immunohistochemical Assays in Breast Cancer
SHINSUKE SASADA, MOMOKO TAKAYA, KANAKO SUZUKI, MUTSUMI FUJIMOTO, HARUKA IKEJIRI, AI AMIOKA, HIDEO SHIGEMATSU, KOJI ARIHIRO and MORIHITO OKADA

Anticancer Research February 2026, 46 (2) 1123-1130; DOI: https://doi.org/10.21873/anticanres.18015
You have access
Clinicopathological Significance of HER2 Expression Redefined by the HER2-low Concept in Ductal Carcinoma In Situ
KOJI TAKADA, SHINICHIRO KASHIWAGI, MAYUKO HIRATA, MARIKO NISHIKAWA, CHIKA WATANABE, YUKIE TAUCHI, KANA OGISAWA, MASATSUNE SHIBUTANI, HARUHITO KINOSHITA and TAMAMI MORISAKI

Anticancer Research February 2026, 46 (2) 901-909; DOI: https://doi.org/10.21873/anticanres.17997
You have access
c-MYC Protein Expression Patterns in Laryngeal-Hypopharyngeal Squamous Cell Carcinomas
SOTIRIOS PAPOULIAKOS, ARISTEIDIS CHRYSOVERGIS, VASILEIOS PAPANIKOLAOU, DIMITRIOS TSOUNIS, DIMITRIOS ROUKAS, DIMITRIOS RIGOPOULOS, GEORGE PAPANASTASIOU, EVANGELOS TSIAMBAS, PAVLOS PANTOS, NIKOLAOS POULIANITIS, ANDREAS C. LAZARIS, NIKOLAOS KAVANTZAS and EFTHYMIOS KYRODIMOS

Anticancer Research November 2025, 45 (11) 4933-4939; DOI: https://doi.org/10.21873/anticanres.17838
You have access
Association of Tumor Budding Grade With Immunohistochemical Expression of Thrombin and PAR-1 in Pancreatic Ductal Adenocarcinoma
ANTEJA KRIŠTIĆ, IVAN FRANIN, TONĆI VODOPIĆ, HRVOJE LONČAR, TOMISLAVA GRGURIĆ, MONICA STEPHANY KIRIGIN, ČEDNA TOMASOVIĆ-LONČARIĆ and HRVOJE ČUPIĆ

Anticancer Research November 2025, 45 (11) 5191-5202; DOI: https://doi.org/10.21873/anticanres.17859
You have access
High Claudin 18.2 Expression Predicts Favorable Outcomes in Pancreatic Ductal Adenocarcinoma After Curative Resection
HYEBIN CHA, EDEN DEMERE AMARE, YUN KYUNG JUNG, YOUNG HA OH, WOON YONG JUNG, SEUNGYUN JEE, SEONGSIK BANG, HWANGKYU SON, KIHYUK SONG, HOSUB PARK, JAEKYUNG MYUNG, SEUNGSAM PAIK, YESEUL KIM and HYUNSUNG KIM

Anticancer Research October 2025, 45 (10) 4565-4573; DOI: https://doi.org/10.21873/anticanres.17802
You have access
Sellar Metastatic Follicular Thyroid Carcinoma With Novel Mutations Clinically Mimicking Pituitary Macroadenoma: Intraoperative Frozen Section Diagnosis Challenges
JEFFREY HONG, RUOHAO FAN, YING GAO, GREGORY MOES and JINPING LAI

Anticancer Research October 2025, 45 (10) 4637-4641; DOI: https://doi.org/10.21873/anticanres.17809
You have access
Detection of Somatostatin Receptors by Ligand Derivative Staining in Breast Tumors
KENTO IIDA, ERINA IWABUCHI, YASUHIRO MIKI, KOKI HASEGAWA, YASUYO OHI, YOSHIAKI RAI, YASUAKI SAGARA, TAKANORI ISHIDA, HIRONOBU SASANO and TAKASHI SUZUKI

Anticancer Research August 2025, 45 (8) 3221-3230; DOI: https://doi.org/10.21873/anticanres.17684
Open Access
Nuclear Localization of Chitinase 3-like 1 Is a Novel Biomarker for Detecting the Early Stage of Inflammation-associated Dysplasia in the Oral Cavity
YUI TERATANI, TAKAYUKI SADANAGA, SIYUAN WANG, JINGO KUSUKAWA and EMIKO MIZOGUCHI

Anticancer Research August 2025, 45 (8) 3469-3478; DOI: https://doi.org/10.21873/anticanres.17708
Open Access
Impact of Warm Ischemia Time on HER2 Expression in Breast Cancer Surgical Specimens
NOBUYASU SUGANUMA, YUKA MATSUBARA, AKARI TAKAHASHI, TAKASHI YAMANAKA, TOSHINARI YAMASHITA, EMI YOSHIOKA, KAE KAWACHI, TOMONORI YOKOSE, HIROTO NARIMATSU, DAISUKE HOSHINO, YOHEI MIYAGI and AYA SAITO

Anticancer Research December 2024, 44 (12) 5225-5230; DOI: https://doi.org/10.21873/anticanres.17350
You have access
Immunohistochemical Expression and Significance of Preferentially Expressed Antigen in Melanoma (PRAME) in Gynecological Tumors: A Single-institution Retrospective Analysis
YUNJOO CHO and HYUN-SOO KIM

Anticancer Research December 2024, 44 (12) 5515-5524; DOI: https://doi.org/10.21873/anticanres.17377

Main menu

User menu

Search

immunohistochemistry

Pages